
DARPA Launches Project to Develop Non-Hallucinogenic Psychedelic Drugs
DARPA launches Focused Pharma project to develop non-hallucinogenic psychedelic drugs for treating mental health conditions in military settings
- •DARPA initiates Focused Pharma to explore non-hallucinogenic psychedelics
- •Project aims to treat PTSD, depression, and anxiety without hallucinations
- •Research influenced by promising results from private clinical studies
by armee-americaine-chercher-psychedelique-non-hallucinogenes


















